Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-038693
Filing Date
2024-03-29
Accepted
2024-03-29 16:30:12
Documents
1
Period of Report
2024-03-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3695
  Complete submission text file 0000950170-24-038693.txt   5125
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Issuer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Whiting Nancy (Reporting) CIK: 0001880609 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41989 | Film No.: 24804421